Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01418911
Other study ID # 23/2011
Secondary ID
Status Not yet recruiting
Phase N/A
First received August 16, 2011
Last updated April 30, 2012
Start date August 2011
Est. completion date December 2013

Study information

Verified date July 2011
Source Assuta Hospital Systems
Contact Liza Cnaani, MA
Email abarbnel_l@mac.org.il
Is FDA regulated No
Health authority Israel: MOH, Bait Balev
Study type Observational

Clinical Trial Summary

This study will expand the understanding of factors associated with adherence to self care and the diabetes control among diabetes type 2 patients. The theoretical framework of the study incorporates central variables from two theoretical models: a cognitive model of health behavior - "Health Belief Model", and the Stress and Coping model. The study is innovative in its focus on the association between the patient's attachment style and adherence to self care and diabetes control, a topic less studied among diabetes patients, in addition to cognitive, social and emotional variables. Further emphasis is upon a comparison of the study model between males and females.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 300
Est. completion date December 2013
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- type 2 diabetes

- 40-70 years of age

- Hebrew speaking

- members of maccabi healthcare services

Study Design

N/A


Related Conditions & MeSH terms


Intervention

Other:
questionnaire
questionnaire only

Locations

Country Name City State
Israel Maccabi Healthcare Services Tel Aviv

Sponsors (1)

Lead Sponsor Collaborator
Assuta Hospital Systems

Country where clinical trial is conducted

Israel, 

See also
  Status Clinical Trial Phase
Recruiting NCT03087032 - Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) Phase 4
Completed NCT01298518 - A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients Phase 1
Withdrawn NCT04662164 - A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin Phase 1/Phase 2